Isracann Biosciences Inc. (ISCNF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 14, 2026
Isracann Biosciences Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ISCNF has 176.73 million shares outstanding.
| Current Share Class | 176.73M |
| Shares Outstanding | 176.73M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +3.72% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.01% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.30
| Current Ratio | 0.30 |
| Quick Ratio | 0.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -252.75% and return on invested capital (ROIC) is -77.60%.
| Return on Equity (ROE) | -252.75% |
| Return on Assets (ROA) | -34.99% |
| Return on Invested Capital (ROIC) | -77.60% |
| Return on Capital Employed (ROCE) | -74.10% |
| Weighted Average Cost of Capital (WACC) | 102.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 17.83 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 41.70 |
| Average Volume (20 Days) | 47,349 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.71M |
| Pretax Income | -3.47M |
| Net Income | -3.47M |
| EBITDA | -1.67M |
| EBIT | -1.71M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 151,461 in cash and n/a in debt, with a net cash position of 151,461 or 0.00 per share.
| Cash & Cash Equivalents | 151,461 |
| Total Debt | n/a |
| Net Cash | 151,461 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 95,495 |
| Book Value Per Share | 0.00 |
| Working Capital | -554,783 |
Cash Flow
| Operating Cash Flow | -1.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ISCNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.87% |
| Shareholder Yield | -6.87% |
| Earnings Yield | -1,961,653.67% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |